Effect of blood pressure-lowering agents on microvascular function in people with small vessel diseases (TREAT-SVDs): a multicentre, open-label, randomised, crossover trialAnna Kopczak, Saskia A.J. Lesnik Oberstein, Keith W. Muir et al.|The Lancet Neurology|2023Cited by 38
Blood-brain barrier leakage hotspots collocating with brain lesions due to sporadic and monogenic small vessel diseaseSalvatore Rudilosso, Joanna M. Wardlaw, Michael Stringer et al.|Journal of Cerebral Blood Flow & Metabolism|2023Cited by 25
Heterogeneity and Penumbra of White Matter Hyperintensities in Small Vessel Diseases Determined by Quantitative MRIPaulien Voorter, Walter H. Backes, Michael Stringer et al.|Stroke|2024Cited by 23
Prevalence and Significance of the Vessel-Cluster Sign on Susceptibility-Weighted Imaging in Patients With Severe Small Vessel DiseaseSalvatore Rudilosso, E. Chui, Michael Stringer et al.|Neurology|2022Cited by 22
Imaging neurovascular, endothelial and structural integrity in preparation to treat small vessel diseases. The INVESTIGATE-SVDs study protocol. Part of the SVDs@Target projectGordon W. Blair, Joanna M. Wardlaw, Michael Stringer et al.|Cerebral Circulation - Cognition and Behavior|2021Cited by 20